| Variables (number of case) | 5-years DFS (%) | p-value | HRa | 95% CIb | |
| Univariate analysis | Multivariate analysis | ||||
| Age |
| 0.92 | _ |
|
|
| ≤52 (70) | 44.5 |
|
| _ | _ |
| >52 (63) | 43.7 |
|
| _ | _ |
| WHO PS |
| 0.48 | _ |
|
|
| 0 (47) | 48.6 |
|
| _ | _ |
| 1 - 2 (86) | 41.4 |
|
| _ | _ |
| Hb level |
| 0.017 | 0.03 |
|
|
| ≤11 (46) | 29.0 |
|
| 1 | _ |
| >11 (79) | 49.7 |
|
| 0.59 | [0.37 - 0.96] |
| Unknown (8) | _ |
|
| _ | _ |
| Tumor size |
| 0.19 | _ |
|
|
| ≤6 (88) | 47.7 |
|
| _ | _ |
| >6 (45) | 36.5 |
|
| _ | _ |
| FIGO stage |
| 0.19 | _ |
|
|
| I/II (49) | 49.7 |
|
| _ | _ |
| III/IVA (84) | 39.9 |
|
| _ | _ |
| RLNc metastasis |
| 0.007 | 0.01 |
|
|
| No (73) | 53.8 |
|
| 1 | _ |
| Yes (60) | 32.1 |
|
| 1.86 | [1.15 - 2.99] |
| CCT cycles |
| 0.86 | _ |
|
|
| ≤5 (69) | 49.0 |
|
| _ | _ |
| >5 (46) | 47.0 |
|
| _ | _ |
| Unknown (11) | _ |
|
| _ | _ |
| OTT |
| 0.37 | _ |
|
|
| ≤60 | 38.4 |
|
| _ | _ |
| >60 | 48.4 |
|
| _ | _ |